Perinatal Outcome After Premature Rupture of Membranes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-05-31

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Premature rupture of membranes is an important cause of neonatal morbidity and mortality, mainly because of the complications associated with this pathology (oligohydramnios, cord compression or prolapse, infection). When rupture of the membranes occur the risk of cord compression increases but there is little evidence regarding this complication and amniotic fluid volume. The investigator's focus are the perinatal outcomes according to amniotic fluid volume (\< 5 or \>5).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictive Score for Neonatal Mortality for Women With Premature Rupture of Membranes Between 22 and 28 Weeks of Gestation

NCT03108404

Perinatal Mortality Premature Rupture of Fetal Membranes

UNKNOWN

Outpatient Management of Preterm Prelabor Rupture of Membranes

NCT05755841

Management of Preterm Prelabor Rupture of Membranes

COMPLETED

Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections

NCT03251898

Premature Rupture of Membrane Neonatal Infection

COMPLETED

PROMComplete for Determination of Rupture of Fetal Membranes

NCT02369601

Fetal Membranes, Premature Rupture

UNKNOWN

Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)

NCT03491826

Premature Rupture of Membrane

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fetal Membranes Premature Rupture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Amniotic Fluid Volume > 5

Pregnant patients with gestations between 24-34 weeks with premature rupture of membranes that, when the decision was made to interrupt the pregnancy, had amniotic fluid volume index above 5.1

No interventions assigned to this group

Amniotic Fluid Volume < 5

Pregnant patients with gestations between 24-34 weeks with premature rupture of membranes that, when the decision was made to interrupt the pregnancy, had amniotic fluid volume index of 5 or less.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age between 24-34 weeks.
* Confirmed diagnosis of premature rupture of membranes.

Exclusion Criteria

* Twin pregnancies.
* Obstetric pathologies that require immediate termination of pregnancy (severe preeclampsia, abruptio placenta, cord prolapse).
* Termination of pregnancy (whatever the reason) before complete corticoid treatment.
* Incomplete recollection of all data required for analysis.

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No